Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease-MedSci.cn

Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease

Gan, LY; Xie, PP; Tan, Y; Wei, G; Yuan, XJ; Lu, ZF; Pratt, R; Zhou, YC; Hui, AM; Li, KX; Fang, Y; Zuo, L

Zuo, L (通讯作者)，Peking Univ, Dept Nephrol, Peoples Hosp, Unit 10C Ward Bldg,11 Xizhimennan St, Beijing 100044, Peoples R China.;Li, KX (通讯作者)，Chinese Acad Med Sci, Beijing Hosp, Clin Trial Ctr, Natl Ctr Gerontol,Inst Geriatr Med, Beijing 100730, Peoples R China.;Fang, Y (通讯作者)，Peking Univ, Dept Pharm, Peoples Hosp, 133 Fuchengmennei St, Beijing 100034, Peoples R China.

DRUGS IN R&D, 2022; 22 (2): 119

Abstract

Background and Objective Anemia caused by iron depletion is common in patients with hemodialysis-dependent stage 5 chronic kidney disease (CKD-5HD) pa......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease

科室

工具

服务